The prevalence of azole-resistant Aspergillus fumigatus (ARAF) among chronic pulmonary
aspergillosis (CPA) patients treated with azoles in Japan is unknown. The aim of this study …

Aspergillus antibody testing is key for the clinical diagnosis of chronic pulmonary aspergillosis
(CPA) with high sensitivity. However, false-negative results in patients with CPA might be …

Objectives This study examined Mycobacterium tuberculosis (MTB)-secreted MPT64 as a
surrogate of bacterial viability for the diagnosis of active pulmonary TB (PTB) and for follow-up …

Objective To assess the prevalence and risk factors of recurrence of chronic pulmonary
aspergillosis (CPA) after discontinuation of antifungal triazoles. Method We reviewed the medical …

High serum total immunoglobulin E (IgE) levels have been reported in chronic pulmonary
aspergillosis (CPA). However, researchers have not verified if they reflect the disease activity. …

Background: While nontuberculous mycobacterial (NTM) pleuritis rarely complicates
pulmonary NTM infection, high mortality has been reported in case reports and small studies. …

Background Hemoptysis can cause a life-threatening condition and often needs to be
treated urgently. Nearly 20% of hemoptysis cases are diagnosed as cryptogenic after clinical …

When Aspergillus , an ubiquitous, saprophytic fungus, is detected in respiratory tract specimens
collected from chronic respiratory disease patients, it is important to determine whether it …

Objectives A recently released new QuantiFERON (QFT) product, QFT TB Gold plus (QFT-plus),
is optimized for both CD4 and CD8 responses and reported to have higher sensitivity …

Objectives Interferon-gamma release assays (IGRAs) can be positive in patients infected with
Mycobacterium kansasii (M. kansasii), which carries some of Mycobacterium tuberculosis …